Calabar Capital
Institutional investment in Women's Health & Healthcare AI.
The founders
JM
The company
Calabar Capital is developing an allocator-led institutional investment platform offering diversified access to specialist managers across Women's Health and Healthcare AI. The idea is to layer institutional-grade manager selection, portfolio construction and oversight on top of a fragmented field of specialists spanning multiple healthcare domains, company stages and geographies.
The company frames Women's Health as chronically underserved and Healthcare AI as a rapidly widening opportunity — two theses that are hard for generalist allocators to access cleanly today. An allocator-led structure is a bet that the alpha here sits with specialist managers, not one-size-fits-all funds.
Founded in 2026 by Jillian MacNab, the firm is being built around a conviction that women's health has substantial unmet needs and that specialist expertise beats broad exposure. Beyond the founder, the company hasn't disclosed further team pedigree.
With founder Jillian MacNab at the helm, the pitch rests on disciplined manager selection and oversight rather than picking individual companies — an allocator's craft. It's early days, so the proof will be in the managers they assemble.
Who else is building in this space
Companies working on the same thing, at every stage.
AI-driven analytics for public and private markets.
Managed property investment for UK professionals.
Vertically integrated investment in middle-market multifamily assets.
Property investment services maximizing portfolio returns.
Direct investment in diversified commercial real estate.
Thousands more founded every month.
Dealroom tracks new companies as they appear — founders, funding and signals, over the API or in the platform.